# OnCo record nct04718883 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04718883/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04718883", "NCT04718883" ;
  schema:name "CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma"@en ;
  schema:description "A phase 2 trial of CD19-targeted Chimeric Antigen Receptor (CAR) T Cells in mantle cell lymphoma, run by Shanghai Ming Ju Biotechnology Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04718883/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04718883> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2021-01-13" ;
  onco:cancers <https://onco.cc/cancers/mantle-cell-lymphoma/> ;
  onco:companies <https://onco.cc/companies/jw-therapeutics/> .